vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and UNITED BANKSHARES INC (UBSI). Click either name above to swap in a different company.
UNITED BANKSHARES INC is the larger business by last-quarter revenue ($318.4M vs $207.8M, roughly 1.5× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 40.5%, a 16.9% gap on every dollar of revenue. UNITED BANKSHARES INC produced more free cash flow last quarter ($481.2M vs $142.2M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
United Bankshares Inc. (WV) is a regional financial holding company operating mainly across the Mid-Atlantic and Southeastern United States. It provides full-spectrum banking solutions including consumer and commercial lending, deposit products, wealth management, and mortgage services for individual, small business and corporate clients.
IDYA vs UBSI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $318.4M |
| Net Profit | $119.2M | $128.8M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | 50.2% |
| Net Margin | 57.4% | 40.5% |
| Revenue YoY | — | 21.6% |
| Net Profit YoY | 330.1% | 36.5% |
| EPS (diluted) | $1.33 | $0.91 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $318.4M | ||
| Q3 25 | $207.8M | $323.3M | ||
| Q2 25 | — | $306.0M | ||
| Q1 25 | — | $289.6M | ||
| Q4 24 | — | $261.9M | ||
| Q3 24 | $0 | $262.2M | ||
| Q2 24 | $0 | $255.9M | ||
| Q1 24 | $0 | $254.7M |
| Q4 25 | — | $128.8M | ||
| Q3 25 | $119.2M | $130.7M | ||
| Q2 25 | — | $120.7M | ||
| Q1 25 | — | $84.3M | ||
| Q4 24 | — | $94.4M | ||
| Q3 24 | $-51.8M | $95.3M | ||
| Q2 24 | $-52.8M | $96.5M | ||
| Q1 24 | $-39.6M | $86.8M |
| Q4 25 | — | 50.2% | ||
| Q3 25 | 52.2% | 50.9% | ||
| Q2 25 | — | 49.7% | ||
| Q1 25 | — | 36.9% | ||
| Q4 24 | — | 46.2% | ||
| Q3 24 | — | 45.7% | ||
| Q2 24 | — | 45.1% | ||
| Q1 24 | — | 42.5% |
| Q4 25 | — | 40.5% | ||
| Q3 25 | 57.4% | 40.4% | ||
| Q2 25 | — | 39.5% | ||
| Q1 25 | — | 29.1% | ||
| Q4 24 | — | 36.0% | ||
| Q3 24 | — | 36.3% | ||
| Q2 24 | — | 37.7% | ||
| Q1 24 | — | 34.1% |
| Q4 25 | — | $0.91 | ||
| Q3 25 | $1.33 | $0.92 | ||
| Q2 25 | — | $0.85 | ||
| Q1 25 | — | $0.59 | ||
| Q4 24 | — | $0.70 | ||
| Q3 24 | $-0.60 | $0.70 | ||
| Q2 24 | $-0.68 | $0.71 | ||
| Q1 24 | $-0.53 | $0.64 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | — |
| Total DebtLower is stronger | — | $531.8M |
| Stockholders' EquityBook value | $1.1B | $5.5B |
| Total Assets | $1.2B | $33.7B |
| Debt / EquityLower = less leverage | — | 0.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $786.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $920.0M | — | ||
| Q2 24 | $701.7M | — | ||
| Q1 24 | $698.8M | — |
| Q4 25 | — | $531.8M | ||
| Q3 25 | — | $250.0M | ||
| Q2 25 | — | $250.0M | ||
| Q1 25 | — | $250.0M | ||
| Q4 24 | — | $540.4M | ||
| Q3 24 | — | $260.3M | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.5B |
| Q4 25 | — | $5.5B | ||
| Q3 25 | $1.1B | $5.4B | ||
| Q2 25 | — | $5.4B | ||
| Q1 25 | — | $5.3B | ||
| Q4 24 | — | $5.0B | ||
| Q3 24 | $1.2B | $5.0B | ||
| Q2 24 | $931.7M | $4.9B | ||
| Q1 24 | $935.3M | $4.8B |
| Q4 25 | — | $33.7B | ||
| Q3 25 | $1.2B | $33.4B | ||
| Q2 25 | — | $32.8B | ||
| Q1 25 | — | $32.8B | ||
| Q4 24 | — | $30.0B | ||
| Q3 24 | $1.2B | $29.9B | ||
| Q2 24 | $973.7M | $30.0B | ||
| Q1 24 | $961.5M | $30.0B |
| Q4 25 | — | 0.10× | ||
| Q3 25 | — | 0.05× | ||
| Q2 25 | — | 0.05× | ||
| Q1 25 | — | 0.05× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | — | 0.25× | ||
| Q1 24 | — | 0.30× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $498.9M |
| Free Cash FlowOCF − Capex | $142.2M | $481.2M |
| FCF MarginFCF / Revenue | 68.4% | 151.1% |
| Capex IntensityCapex / Revenue | 0.0% | 5.6% |
| Cash ConversionOCF / Net Profit | 1.19× | 3.87× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $828.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $498.9M | ||
| Q3 25 | $142.2M | $150.6M | ||
| Q2 25 | — | $89.4M | ||
| Q1 25 | — | $120.0M | ||
| Q4 24 | — | $445.5M | ||
| Q3 24 | $-49.2M | $123.6M | ||
| Q2 24 | $-32.9M | $61.2M | ||
| Q1 24 | $-43.8M | $124.4M |
| Q4 25 | — | $481.2M | ||
| Q3 25 | $142.2M | $146.4M | ||
| Q2 25 | — | $85.2M | ||
| Q1 25 | — | $116.1M | ||
| Q4 24 | — | $433.3M | ||
| Q3 24 | $-49.7M | $122.0M | ||
| Q2 24 | $-33.9M | $58.2M | ||
| Q1 24 | $-45.1M | $119.6M |
| Q4 25 | — | 151.1% | ||
| Q3 25 | 68.4% | 45.3% | ||
| Q2 25 | — | 27.8% | ||
| Q1 25 | — | 40.1% | ||
| Q4 24 | — | 165.4% | ||
| Q3 24 | — | 46.5% | ||
| Q2 24 | — | 22.7% | ||
| Q1 24 | — | 47.0% |
| Q4 25 | — | 5.6% | ||
| Q3 25 | 0.0% | 1.3% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 1.9% |
| Q4 25 | — | 3.87× | ||
| Q3 25 | 1.19× | 1.15× | ||
| Q2 25 | — | 0.74× | ||
| Q1 25 | — | 1.42× | ||
| Q4 24 | — | 4.72× | ||
| Q3 24 | — | 1.30× | ||
| Q2 24 | — | 0.63× | ||
| Q1 24 | — | 1.43× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
